Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Zoom
ZM
|
+$96M |
| 2 |
Match Group
MTCH
|
+$81.3M |
| 3 |
Peloton Interactive
PTON
|
+$75.6M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$55.6M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$50.7M |
Top Sells
| 1 |
Apple
AAPL
|
+$201M |
| 2 |
Microsoft
MSFT
|
+$112M |
| 3 |
IAC Inc
IAC
|
+$77.1M |
| 4 |
Amazon
AMZN
|
+$73.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$52.8M |
Sector Composition
| 1 | Technology | 26.26% |
| 2 | Healthcare | 14.68% |
| 3 | Consumer Discretionary | 13.69% |
| 4 | Communication Services | 10.36% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Archrock
AROC
$4.35B
| $1.59M | ﹤0.01% |
294,600
+4,500
| +2% | +$24.2K |
|
|
SDC
1827
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
| $1.58M | ﹤0.01% |
135,400
+8,300
| +7% | +$96.9K |
|
1828
Artivion
AORT
$1.94B
| $1.58M | ﹤0.01% |
85,500
-1,700
| -2% | -$31.4K |
|
1829
Amphastar Pharmaceuticals
AMPH
$1.32B
| $1.57M | ﹤0.01% |
83,900
| – | – |
|
1830
Rocket Pharmaceuticals
RCKT
$343M
| $1.57M | ﹤0.01% |
68,800
+1,600
| +2% | +$36.6K |
|
|
ECHO
1831
DELISTED
Echo Global Logistics, Inc.
ECHO
| $1.57M | ﹤0.01% |
60,900
| – | – |
|
1832
Ameresco
AMRC
$1.48B
| $1.57M | ﹤0.01% |
46,900
+1,600
| +4% | +$53.4K |
|
|
EGIO
1833
DELISTED
Edgio, Inc. Common Stock
EGIO
| $1.56M | ﹤0.01% |
6,780
+195
| +3% | +$44.9K |
|
|
GWB
1834
DELISTED
Great Western Bancorp, Inc.
GWB
| $1.56M | ﹤0.01% |
125,400
| – | – |
|
1835
Innoviva
INVA
$1.25B
| $1.56M | ﹤0.01% |
149,300
+2,300
| +2% | +$24K |
|
|
CBB
1836
DELISTED
Cincinnati Bell Inc.
CBB
| $1.55M | ﹤0.01% |
103,100
+1,500
| +1% | +$22.5K |
|
1837
National Research Corp
NRC
$366M
| $1.55M | ﹤0.01% |
31,400
+800
| +3% | +$39.4K |
|
|
PETQ
1838
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $1.54M | ﹤0.01% |
46,900
+2,400
| +5% | +$79K |
|
|
RTL
1839
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
| $1.54M | ﹤0.01% |
245,960
+7,700
| +3% | +$48.3K |
|
|
BRKL
1840
DELISTED
Brookline Bancorp
BRKL
| $1.54M | ﹤0.01% |
177,900
| – | – |
|
1841
Core Laboratories
CLB
$577M
| $1.54M | ﹤0.01% |
100,800
+1,600
| +2% | +$24.4K |
|
1842
German American Bancorp
GABC
$1.53B
| $1.54M | ﹤0.01% |
56,550
| – | – |
|
1843
Enterprise Financial Services Corp
EFSC
$2.27B
| $1.53M | ﹤0.01% |
56,264
| – | – |
|
1844
Oxford Industries
OXM
$604M
| $1.53M | ﹤0.01% |
38,000
| – | – |
|
1845
OneSpan
OSPN
$578M
| $1.53M | ﹤0.01% |
73,100
+1,300
| +2% | +$27.2K |
|
1846
John B. Sanfilippo & Son
JBSS
$724M
| $1.53M | ﹤0.01% |
20,276
+600
| +3% | +$45.2K |
|
1847
BGC Group
BGC
$4.76B
| $1.53M | ﹤0.01% |
635,708
+19,800
| +3% | +$47.5K |
|
1848
Unisys
UIS
$276M
| $1.52M | ﹤0.01% |
142,700
+3,400
| +2% | +$36.3K |
|
1849
Magnite
MGNI
$3.4B
| $1.52M | ﹤0.01% |
219,100
+4,100
| +2% | +$28.5K |
|
|
NXGN
1850
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $1.52M | ﹤0.01% |
119,100
+1,800
| +2% | +$22.9K |
|